Back to dashboard
Episode 545
DIP Episode 545 - USMLE Step 2CK/3 Rapid Review Series 116
MixedMedium4 - HighHas Q&A
Step 2Step 3MedicineUSMLEStep 2Step 3
Topic
Tinea infections; CYP450 drug interactions; Anticoagulation management; Idiopathic Pulmonary Fibrosis (IPF); Autoimmune vasculitis syndromes.
Key Takeaway
When managing tinea requiring systemic antifungals, always prioritize the agent that does not induce Cytochrome P450 enzymes to prevent life-threatening drug interactions with anticoagulants or Vitamin D supplementation.
Runtime: 12 min
Published: 2024-08-07
Completed audio: Yes
Completed notes: Yes
Anki made: Yes
Section: RAPID REVIEW SERIES
Episode Notes
Source / episode info
- Episode: 545
- Title: Divine Intervention Episode 545: USMLE Step 2 CK/3 Rapid Review Series 116
- Published: 2024-08-07
- Source: Episode page
One-liner
This episode is a rapid review emphasizing the specific order of tinea species (Trichophyton, Microsporum, Epidermophyton), the critical importance of CYP450 enzyme induction in drug interactions (e.g., Warfarin, Vitamin D), and high-yield associations for autoimmune vasculitis treated with steroids and cyclophosphamide.
High-yield summary
- Tinea Species Order: The three species to memorize are Trichophyton (most common), Microsporum, and Epidermophyton.
- Antifungal Choice: For tinea involving the nails or scalp, systemic antifungals (Terbinafine is preferred) must be used; topical agents are insufficient.
- CYP450 Principle: Drugs that induce CYP450 (e.g., Griseofulvin, Carbamazepine, Rifampin, Phenytoin, St. John's Wort) accelerate the metabolism of other drugs metabolized by this system, leading to therapeutic failure and potential complications (e.g., reduced Warfarin effect).
- Anticoagulation Monitoring: In patients on warfarin for atrial fibrillation or mechanical valves, adding a CYP450 inducer can cause subtherapeutic INR levels, increasing the risk of thromboembolism/stroke.
- IPF Location: Idiopathic Pulmonary Fibrosis (IPF) has a predilection for the bases of the lungs.
- Autoimmune Combinations: The combination of steroids and cyclophosphamide is used to treat Polyarteritis Nodosa, Wegener's Granulomatosis, Churg-Strauss Syndrome, and Goodpasture Syndrome.
Learning objectives
- Identify the three species of dermatophytes causing tinea infections in correct order of prevalence.
- Select appropriate systemic antifungal agents for tinea involving keratinized tissue (nails/scalp) while considering drug interactions.
- Explain the mechanism and clinical consequences of CYP450 enzyme induction on drugs like Warfarin, Vitamin D, and oral contraceptives.
- Recognize the classic pulmonary pattern and location associated with Idiopathic Pulmonary Fibrosis (IPF).
- List the four autoimmune vasculitis syndromes treated with a combination of steroids and cyclophosphamide.
Board exam buzzwords
| Condition | Key Finding | Association | Board Exam Tip |
| Tinea infections | Nail/Scalp involvement | Systemic antifungals required (Terbinafine) | Always remember the species order: Trichophyton > Microsporum > Epidermophyton. |
| CYP450 Induction | Accelerated drug metabolism | Rifampin, Carbamazepine, Phenytoin, St. John's Wort | If a patient is on Warfarin or OC Ps and starts an inducer, assume the anticoagulant/hormone effect will be lost. |
| Atrial Fibrillation (A-fib) | High stroke risk | Anticoagulation (Warfarin, DOA Cs) | When monitoring INR in A-fib patients, always consider potential CYP450 induction from other drugs. |
| Idiopathic Pulmonary Fibrosis (IPF) | Basal predominance of fibrosis | Interstitial Lung Disease (ILD) | The predilection for the bases is a key distinguishing feature on imaging/pathology. |
Rapid review table
| Topic | Key Point | Context | Exam Relevance |
| Tinea Management | Systemic antifungals needed | Nail or scalp involvement | Topical agents are insufficient; Terbinafine is preferred due to low CYP induction risk. |
| Drug Interactions | CYP450 Induction | Rifampin, Carbamazepine, Phenytoin, St. John's Wort | These drugs rapidly metabolize other medications (e.g., Warfarin, Vitamin D), leading to therapeutic failure. |
| Anticoagulation | INR monitoring | A-fib/Mechanical valves | If a CYP inducer is added, the patient is likely under-anticoagulated (low INR). |
| Autoimmune Vasculitis | Steroids + Cyclophosphamide | Polyarteritis Nodosa, Wegener's, Churg-Strauss, Goodpasture Syndrome | This combination therapy is highly specific and must be memorized. |
Board-speak -> diagnosis
| Board-speak / Vignette phrase | Diagnosis / Concept | Why it fits |
| A patient with tinea corporis requires systemic antifungal therapy due to involvement of the nails or scalp. Which agent is preferred? | Terbinafine (over Griseofulvin) | Terbinafine does not induce CYP450, minimizing drug interaction risk compared to Griseofulvin. |
| A patient with atrial fibrillation and mechanical heart valves requires warfarin prophylaxis for stroke prevention. They are subsequently started on carbamazepine for trigeminal neuralgia. What is the expected complication? | Subtherapeutic INR / Increased Thrombosis Risk | Carbamazepine is a potent CYP450 inducer, accelerating Warfarin metabolism and reducing its anticoagulant effect. |
| A patient presents with chronic cough and dyspnea, and chest imaging shows interstitial fibrosis predominantly affecting the lung bases. | Idiopathic Pulmonary Fibrosis (IPF) | IPF classically has a predilection for the lower lobes/bases of the lungs. |
| A rheumatology patient is diagnosed with vasculitis involving multiple organs and requires immunosuppression using high-dose steroids and cyclophosphamide. Which condition might this represent? | Polyarteritis Nodosa, Wegener's, Churg-Strauss, or Goodpasture Syndrome | These four specific autoimmune/vasculitic syndromes are classically treated with this combination therapy. |
| A patient is being treated for tinea capitis and requires systemic antifungals. The physician must choose between Griseofulvin and Terbinafine. Which choice minimizes drug interactions? | Terbinafine | Griseofulvin is a potent CYP450 inducer, posing significant risks when combined with other medications (e.g., Warfarin). |
| A patient on vitamin D supplementation for hypocalcemia develops an infection and is started on rifampin. What metabolic issue must be monitored? | Vitamin D depletion/Therapeutic failure of Vitamin D | Rifampin is a potent CYP450 inducer, rapidly metabolizing and depleting the therapeutic levels of Vitamin D (which is metabolized by CYP enzymes). |
Differential diagnosis / distinguishing features
Pulmonary Fibrosis
| Key Features | Distinguishing Findings | Next Step |
| Idiopathic Pulmonary Fibrosis (IPF) | Interstitial fibrosis predominantly at lung bases/lower lobes. | High suspicion for ILD; requires high-resolution CT and often a surgical lung biopsy for definitive diagnosis. |
| Hypersensitivity Pneumonitis | Often associated with specific environmental antigens (e.g., mold, bird droppings). | History of exposure is key; may show centrilobular nodules on imaging. |
Management pearls
- For tinea involving the nails or scalp, systemic antifungals are mandatory. Terbinafine is generally preferred over Griseofulvin because it does not induce CYP450 enzymes, minimizing drug interaction risk.
- When managing a patient on warfarin who must take an antifungal like Griseofulvin, close monitoring of the INR and potential need for increased Warfarin dosing are critical due to accelerated metabolism.
- In patients with A-fib requiring anticoagulation (INR target 2.0–3.0), any new drug that is a known CYP450 inducer must prompt suspicion of subtherapeutic anticoagulation.
- The combination therapy of steroids and cyclophosphamide is the standard high-yield treatment for four specific vasculitides: Polyarteritis Nodosa, Wegener's Granulomatosis, Churg-Strauss Syndrome, and Goodpasture Syndrome.
Don't miss
🚨
Tinea Species Order: Trichophyton (most common) > Microsporum > Epidermophyton.
🚨
CYP450 Inducers: Remember the classic list: Rifampin, Carbamazepine, Phenytoin, Griseofulvin, St. John's Wort, and Barbiturates. These drugs are metabolic liabilities.
🚨
IPF Predilection: The fibrosis pattern is classically basal/lower lobe predominant.
🚨
Anticoagulation Goal: For most indications (e.g., A-fib), the target INR range for warfarin is 2.0–3.0.
Integration & clinical reasoning
- Pharmacology Integration: Drug interactions are not limited to antifungals; any drug that induces CYP450 can disrupt the metabolism of Vitamin D, oral contraceptives, and anticoagulants. This concept links mycology, endocrinology, and cardiology.
- Rheumatology/Immunology Integration: The treatment regimen (steroids + cyclophosphamide) is a classic board association for specific systemic vasculitides, requiring knowledge beyond just "autoimmune disease."
- Pulmonary Integration: IPF represents an irreversible ILD process; understanding its basal predilection helps differentiate it from other causes of interstitial lung disease.
OMM / COMLEX integration
🦴
For COMLEX: know these viscerosomatics / Chapman points, but don't let OMM distract from emergent diagnosis and management.
- Standard emergency management takes priority in any acute setting (e.g., stroke, adrenal crisis). OMT is adjunctive only after stabilization.
- The concept of drug metabolism and enzyme induction applies broadly to all systems; understanding the liver's role in detoxification is crucial for managing polypharmacy across specialties.
Concept connections / cross-references
- For detailed information on the mechanism and management of fungal infections, review [Episode 37].
- For comprehensive coverage of anticoagulation guidelines (CHA2 DS2-VA Sc score), see [Episode 105].
- For general principles of drug metabolism and enzyme induction, refer to [Episode 48].
High-yield association table
| Condition | Association | Mechanism | Clinical Significance |
| Tinea infections | Trichophyton species | Dermatophyte growth on keratin | Most common cause; remember the order: T. > M. > E. |
| Griseofulvin / Carbamazepine | CYP450 Induction | Enzyme induction accelerates metabolism of co-administered drugs. | Leads to therapeutic failure of anticoagulants (Warfarin) or Vitamin D, increasing risk/complications. |
| Atrial Fibrillation | Stroke Risk | Thrombus formation in the left atrial appendage. | Requires chronic anticoagulation; monitoring is complicated by drug interactions. |
| Idiopathic Pulmonary Fibrosis (IPF) | Basal predominance of fibrosis | Unknown etiology leading to progressive lung scarring. | Helps localize potential pathology and differentiate from other IL Ds. |
Key terms glossary
| Term | Definition | Context | Example |
| CYP450 | Cytochrome P450 enzyme system | Drug metabolism in the liver (primarily). | Rifampin is a potent inducer, speeding up Warfarin breakdown. |
| Tinea | Dermatophytosis; fungal infection of skin/nails. | Diagnosis based on KOH prep or culture. | Tinea pedis (athlete's foot) or tinea unguium (nail fungus). |
| CYP450 Inducer | Drug that increases the activity of CYP450 enzymes. | Pharmacological principle; leads to faster metabolism of other drugs. | Carbamazepine, Phenytoin, Rifampin. |
| Polyarteritis Nodosa | Systemic vasculitis affecting medium-sized arteries. | Autoimmune/Vasculitic syndrome requiring immunosuppression. | Treated with steroids and cyclophosphamide. |
Study optimization
| Topic | Study Approach | Priority | Resources |
| Drug Interactions (CYP450) | Create a "Danger List" of Inducers vs. Substrates. | High | Review the classic list: Rifampin, Carbamazepine, Phenytoin, St. John's Wort. |
| Tinea Management | Memorize species order and preferred systemic agent. | Medium-High | Focus on Trichophyton being most common; Terbinafine for nails/scalp. |
| Autoimmune Vasculitis | Group the four specific diseases treated by steroids + cyclophosphamide. | High | Polyarteritis Nodosa, Wegener's, Churg-Strauss, Goodpasture Syndrome. |
Question pattern recognition
- Pattern: Tinea involving nails or scalp -> Requires systemic antifungals (Terbinafine preferred) because topical agents are insufficient.
- Pattern: Patient on Warfarin + new antifungal/anti-epileptic drug -> Suspect CYP450 induction, leading to subtherapeutic INR and increased thrombotic risk.
- Pattern: Interstitial fibrosis predominantly at the lung bases -> Highly suggestive of Idiopathic Pulmonary Fibrosis (IPF).
Test yourself
Common mistakes to avoid
🚫
Mistake 1: Assuming all tinea are superficial. Tinea involving the nails (onychomycosis) or scalp (tinea capitis) requires systemic antifungals, not just topical agents.
🚫
Mistake 2: Forgetting the CYP450 principle. Never assume a drug is safe; always check if it induces CYP450 when co-administered with anticoagulants, OC Ps, or Vitamin D.
🚫
Mistake 3: Misidentifying IPF location. Remember that IPF has a strong predilection for the bases of the lungs, not necessarily diffuse involvement.
Common traps
⚠️
Trap 1 (Tinea): Choosing Griseofulvin over Terbinafine when both are systemic antifungals because Griseofulvin is often taught first. Always choose Terbinafine to avoid CYP450 induction.
⚠️
Trap 2 (Anticoagulation): Assuming that a patient on warfarin and an inducer will simply need a dose adjustment, rather than recognizing the potential for profound therapeutic failure requiring immediate intervention.
⚠️
Trap 3 (Autoimmunity): Confusing the specific four vasculitides treated with steroids/cyclophosphamide with general autoimmune diseases like SLE or RA.